Anti-EFNA5/ AF1/ EFL5 monoclonal antibody

Anti-EFNA5/ AF1/ EFL5 antibody for FACS & in-vivo assay

Target products collectionGo to EFNA5/EFNA5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0396-Ab-1/ GM-Tg-hg-MP0396-Ab-2Anti-Human EFNA5 monoclonal antibodyHuman
GM-Tg-rg-MP0396-Ab-1/ GM-Tg-rg-MP0396-Ab-2Anti-Rat EFNA5 monoclonal antibodyRat
GM-Tg-mg-MP0396-Ab-1/ GM-Tg-mg-MP0396-Ab-2Anti-Mouse EFNA5 monoclonal antibodyMouse
GM-Tg-cynog-MP0396-Ab-1/ GM-Tg-cynog-MP0396-Ab-2Anti-Cynomolgus/ Rhesus macaque EFNA5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0396-Ab-1/ GM-Tg-felg-MP0396-Ab-2Anti-Feline EFNA5 monoclonal antibodyFeline
GM-Tg-cang-MP0396-Ab-1/ GM-Tg-cang-MP0396-Ab-2Anti-Canine EFNA5 monoclonal antibodyCanine
GM-Tg-bovg-MP0396-Ab-1/ GM-Tg-bovg-MP0396-Ab-2Anti-Bovine EFNA5 monoclonal antibodyBovine
GM-Tg-equg-MP0396-Ab-1/ GM-Tg-equg-MP0396-Ab-2Anti-Equine EFNA5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0396-Ab-1/ GM-Tg-hg-MP0396-Ab-2; GM-Tg-rg-MP0396-Ab-1/ GM-Tg-rg-MP0396-Ab-2;
GM-Tg-mg-MP0396-Ab-1/ GM-Tg-mg-MP0396-Ab-2; GM-Tg-cynog-MP0396-Ab-1/ GM-Tg-cynog-MP0396-Ab-2;
GM-Tg-felg-MP0396-Ab-1/ GM-Tg-felg-MP0396-Ab-2; GM-Tg-cang-MP0396-Ab-1/ GM-Tg-cang-MP0396-Ab-2;
GM-Tg-bovg-MP0396-Ab-1/ GM-Tg-bovg-MP0396-Ab-2; GM-Tg-equg-MP0396-Ab-1/ GM-Tg-equg-MP0396-Ab-2
Products NameAnti-EFNA5 monoclonal antibody
Formatmab
Target NameEFNA5
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-EFNA5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species EFNA5/ AF1/ EFL5 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm004704mouse Efna5 Lentivirus plasmid
    ORF Viral VectorvGMLPm004704mouse Efna5 Lentivirus particle


    Target information

    Target IDGM-MP0396
    Target NameEFNA5
    Gene ID1946,13640,116683,704351,608458,101085951,616742,100073202
    Gene Symbol and SynonymsAF1,AL-1,EFL-5,EFL5,EFNA5,Ephrin-A5,Epl7,EPLG7,GLC1M,LERK-7,LERK7,RAGS
    Uniprot AccessionP52803,P97605
    Uniprot Entry NameEFNA5_HUMAN,EFNA5_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseBreast Cancer
    Gene EnsemblENSG00000184349
    Target ClassificationN/A

    The target: EFNA5, gene name: EFNA5, also named as AF1, EFL5, EPLG7, GLC1M, LERK7, RAGS. Ephrin-A5, a member of the ephrin gene family, prevents axon bundling in cocultures of cortical neurons with astrocytes, a model of late stage nervous system development and differentiation. The EPH and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, particularly in the nervous system. EPH receptors typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin ligands and receptors have been named by the Eph Nomenclature Committee (1997). Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. The Eph family of receptors are similarly divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.